tiprankstipranks
Trending News
More News >

Eterna Therapeutics Completes $6M Private Placement

Story Highlights
Eterna Therapeutics Completes $6M Private Placement

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Eterna Therapeutics ( (ERNA) ).

Ernexa Therapeutics Inc. completed the second closing of its private placement on June 9, 2025, issuing a total of 47,717,087 shares of common stock and 9,332,000 pre-funded warrants, raising approximately $6.0 million in gross proceeds. The company plans to use the funds for general working capital and debt repayment. Additionally, Ernexa is working to regain compliance with Nasdaq’s listing requirements by meeting the Stockholders’ Equity Standard, following a notice received in January 2025 regarding its Market Value of Listed Securities.

More about Eterna Therapeutics

Average Trading Volume: 270,681

Technical Sentiment Signal: Strong Sell

Current Market Cap: $11.23M

See more insights into ERNA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1